Published in J Urol on October 01, 2002
A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol (2009) 1.16
Radioguided surgery in urological malignancies. Indian J Urol (2008) 0.75
Re: Lymphatic mapping and gamma probe guided laparoscopic biopsy of sentinel lymph node in patients with clinical stage I testicular tumor. J Urol (2003) 0.75
Editorial: testis cancer--paradigm for reduction in morbidity without sacrifice of efficacy. J Urol (2002) 0.75
Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies? Clin Transl Imaging (2016) 0.75
Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival. Cancer (2009) 2.64
The natural history of simple renal cysts. J Urol (2002) 2.40
Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients. Eur Urol (2009) 2.03
Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin Chem (2004) 1.93
Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res (2007) 1.68
Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor. Int J Cancer (2010) 1.58
Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med (2003) 1.57
Perioperative management of transurethral surgery for benign prostatic hyperplasia: a nationwide survey in Japan. Int J Urol (2011) 1.55
Laparoscopic partial nephrectomy using microwave tissue coagulator for small renal tumors: usefulness and complications. Eur Urol (2004) 1.55
Nerves at the ventral prostatic capsule contribute to erectile function: initial electrophysiological assessment in humans. Eur Urol (2008) 1.53
Risk factors for overactive bladder in the elderly population: a community-based study with face-to-face interview. Int J Urol (2010) 1.53
Association between physical activity and urinary incontinence in a community-based elderly population aged 70 years and over. Eur Urol (2007) 1.49
Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. J Cancer Res Clin Oncol (2009) 1.48
Laparoscopic simultaneous bilateral adrenalectomy: assessment of feasibility and potential indications. Int J Urol (2011) 1.46
Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol (2010) 1.42
Surgical outcome of laparoscopic radical prostatectomy: summary of early multiinstitutional experience in Japan. Int J Clin Oncol (2003) 1.38
In situ androgen producing enzymes in human prostate cancer. Endocr Relat Cancer (2005) 1.37
Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects. Int J Cancer (2008) 1.33
Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology (2004) 1.33
A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem (2005) 1.28
ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors. Neoplasia (2012) 1.28
Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution. Support Care Cancer (2005) 1.23
The 10-year natural history of simple renal cysts. Urology (2008) 1.19
Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol (2006) 1.18
Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology (2005) 1.17
Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice. Cancer Sci (2007) 1.14
Nocturia and benign prostatic hyperplasia. Urology (2003) 1.13
Prevalence of and risk factors for nocturia: Analysis of a health screening program. Int J Urol (2004) 1.10
Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol (2004) 1.10
Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci (2004) 1.10
The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens (2006) 1.09
Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem (2006) 1.09
Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. Glycobiology (2005) 1.08
Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer. Jpn J Clin Oncol (2008) 1.06
High incidence of inguinal hernia after radical retropubic prostatectomy. Urology (2004) 1.05
Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study. Urology (2006) 1.05
Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer. Jpn J Clin Oncol (2009) 1.05
Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Cancer Res (2003) 1.00
Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J (2008) 1.00
Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria. BJU Int (2013) 0.97
MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis. Int J Oncol (2012) 0.97
Anatomical analysis of the neurovascular bundle supplying penile cavernous tissue to ensure a reliable nerve graft after radical prostatectomy. J Urol (2004) 0.96
Health-related quality of life in men with localized prostate cancer. Int J Urol (2009) 0.96
Human alpha2,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase. J Biol Chem (2003) 0.95
Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer. Prostate (2012) 0.95
Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan. Radiat Oncol (2012) 0.95
Acute renal failure as a result of bilateral ureteral obstruction by Candida albicans fungus balls. Int J Urol (2006) 0.94
High b-value diffusion-weighted MRI for detecting gallbladder carcinoma: preliminary study and results. Eur Radiol (2009) 0.94
Primary choriocarcinoma in the posterior mediastinum. J Urol (2002) 0.94
The efficacy and safety of degarelix, a GnRH antagonist: a 12-month, multicentre, randomized, maintenance dose-finding phase II study in Japanese patients with prostate cancer. Jpn J Clin Oncol (2012) 0.94
Long term survival in a case of concurrent retroperitoneal liposarcoma and renal cell carcinoma: a case report. BMC Res Notes (2014) 0.93
Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy. Jpn J Clin Oncol (2006) 0.93
N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer. Clin Cancer Res (2006) 0.93
Bat3 deficiency accelerates the degradation of Hsp70-2/HspA2 during spermatogenesis. J Cell Biol (2008) 0.92
Steroid sulfatase and estrogen sulfotransferase in human prostate cancer. Prostate (2006) 0.92
Intraoperative electrophysiological confirmation of urinary continence after radical prostatectomy. J Urol (2005) 0.92
Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors. Int J Urol (2011) 0.92
The expression of MUC4 and MUC5AC is related to the biologic malignancy of intraductal papillary mucinous neoplasms of the pancreas. Pancreas (2006) 0.92
Renal epithelioid angiomyolipoma with malignant features: Histological evaluation and novel immunohistochemical findings. Pathol Int (2014) 0.91
Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab (2013) 0.91
Controversies associated with the evaluation of elderly men with localized prostate cancer when considering radical prostatectomy. Int J Clin Oncol (2014) 0.91
Symptom-specific quality of life in patients with benign prostatic hyperplasia. Int J Urol (2002) 0.91
Laparoscopic nephropexy: treatment outcome and quality of life. Int J Urol (2004) 0.91
Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol Int (2004) 0.91
Retroperitoneoscopy-assisted total nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology (2002) 0.90
New trends of immunohistochemistry for making differential diagnosis of breast lesions. Med Mol Morphol (2006) 0.90
Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells. Glycobiology (2010) 0.90
Oncocytic adrenocortical neoplasm arising from adrenal rest in the broad ligament of the uterus. Pathol Int (2014) 0.90
Quality of life after radical prostatectomy in Japanese men: a 5-Year follow up study. Int J Urol (2008) 0.89
Peroxisome proliferator-activated receptor gamma in human prostate carcinoma. Pathol Int (2009) 0.89
Evidence-based clinical practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition). Int J Urol (2008) 0.89
Haptoglobin-beta chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer. Int J Cancer (2008) 0.89
Gene transfer of alpha1,3-fucosyltransferase increases tumor growth of the PC-3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cells. Int J Cancer (2003) 0.89
Functional correlation of trophinin expression with the malignancy of testicular germ cell tumor. Cancer Res (2004) 0.89
The outcome of prostate cancer screening in a normal Japanese population with PSA of 2-4 ng/ml and the free/total PSA under 12%. Jpn J Clin Oncol (2008) 0.88
Clinical significance of ST3Gal IV expression in human renal cell carcinoma. Oncol Rep (2002) 0.88
Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis. Jpn J Clin Oncol (2004) 0.88
Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol (2005) 0.87
Potentiation of potassium currents by beta-adrenoceptor agonists in human urinary bladder smooth muscle cells: a possible electrical mechanism of relaxation. Pharmacology (2008) 0.87
Salvage radiotherapy for biochemical recurrence after radical prostatectomy. BJU Int (2005) 0.87
Changes in quality of life in first year after radical prostatectomy by retropubic, laparoscopic, and perineal approach: Multi-institutional longitudinal study in Japan. Urology (2006) 0.87
Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan. Int J Clin Oncol (2012) 0.87
Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases. Pathol Int (2003) 0.87
Dynamic contrast-enhanced subtraction magnetic resonance imaging in diagnostics of testicular torsion. Urology (2006) 0.86
Intravenous extended liposarcoma arising from renal sinus. Int J Urol (2007) 0.86
Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma. Cancer (2002) 0.86
Development of Japanese version of the UCLA Prostate Cancer Index: a pilot validation study. Int J Clin Oncol (2002) 0.86